Nuri.Ta

NURI.TA's capital structure shows a low debt-to-equity ratio of 0.13, indicating a conservative leverage position. The company holds 3.86 million in cash and equivalents, which is 17% of total assets, and has a current ratio of 2.29, suggesting strong short-term liquidity. However, the company's operating cash flow is negative at -7.53 million, and free cash flow is -11.61 million, indicating ongoing cash burn.

Profitability metrics are severely negative, with a return on equity of -55.71% and a return on assets of -41.41%. These figures are well below the typical performance of the specialty chemicals industry, which usually sees positive returns. The company reported a net loss of 9.42 million, with operating income also in the red at -8.81 million, signaling significant operational challenges.

Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue of 327 million suggests a potentially concentrated business model. The absence of detailed segment reporting limits the ability to assess diversification or regional risk.

Growth trajectory is unclear due to the lack of historical revenue data, but the current financial performance suggests a contraction in operations. The company's capital expenditures of -4.02 million indicate ongoing investment, though this is not offsetting the negative cash flows from operations.

Risk factors include the company's negative cash flows and profitability, which could lead to liquidity constraints if not addressed. The risk assessment indicates low dilution potential, and no immediate filing-based liquidity or dilution flags were detected. However, the company's financial position remains fragile.

Recent events, including filings and transcripts, do not show any significant developments that would alter the company's current financial trajectory. The absence of recent positive news or strategic announcements suggests a period of operational stagnation.